Merck & Co Earnings Estimates, EPS & Revenue | NYSE:MRK

Comments

Merck & Co Inc Earnings Estimates

MRKNYSE

Trade with Public

$115.43

-0.18-0.16%

At close: Mar 13, 5:00 PM EST

$115.18

-0.43-0.37%

Pre-Market: 5:45 AM EST

Dividend: The dividend Ex-Date was 1 day ago

Overview NewsEarningsOptions Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Merck & Co Earnings Estimates, EPS & Revenue | NYSE:MRK

Merck & Co (MRK) is scheduled to report Q1 earnings on April 23, 2026. Analysts estimate EPS of $-1.01 and quarterly revenue of $15.93B.

In the most recent quarter (Q4), Merck & Co reported EPS of $2.04, beating estimates of $2.02 by 0.01%. Revenue came in at $16.40B, exceeding the estimate of $16.20B by 0.01%.

Merck & Co has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Merck & Co has averaged an EPS surprise of 0.05% and a revenue surprise of 0.01%.

Earnings Date

Apr 23

EPS Estimate

$-1.010

Quarterly Revenue Estimate

$15.93B

Annual Revenue
(as of Dec 31)

$65.01B

Merck & Co Earnings History

Analyze the earnings history of Merck & Co using advanced sorting and filters.

Loading calendar...

Merck & Co (MRK) Earnings Per Share

The chart below shows Merck & Co's reported EPS compared to analyst estimates over recent quarters.

Merck & Co (MRK) Revenue

The chart below shows Merck & Co's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Merck & Co (NYSE:MRK) reporting earnings?

Merck & Co (MRK) is scheduled to report earnings on April 23, 2026. The last reported earnings were for reported on February 3, 2026 for Q4.

What were the latest earnings per share (EPS) for Merck & Co (NYSE:MRK)?

The Actual EPS was $2.04, which beat the estimate of $2.02.

What were Merck & Co’s (NYSE:MRK) revenues?

The Actual Revenue was $16.40B, which beat the estimate of $16.20B.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$158.23

Ligand Pharmaceuticals Inc

NASDAQ:LGND

$204.30

-1.71%

Merck & Co Earnings Estimates, EPS & Revenue | NYSE:MRK

Merck & Co (MRK) is scheduled to report Q1 earnings on April 23, 2026. Analysts estimate EPS of $-1.01 and quarterly revenue of $15.93B.

In the most recent quarter (Q4), Merck & Co reported EPS of $2.04, beating estimates of $2.02 by 0.01%. Revenue came in at $16.40B, exceeding the estimate of $16.20B by 0.01%.

Merck & Co has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Merck & Co has averaged an EPS surprise of 0.05% and a revenue surprise of 0.01%.

Earnings Date

Apr 23

EPS Estimate

$-1.010

Quarterly Revenue Estimate

$15.93B

Annual Revenue
(as of Dec 31)

$65.01B